🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

MRI Analysis in the Growth of Cerebral Aneurysms

RecruitingNAAges 18 Years - anyAllCHU de Reims
NCT06705452 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

An intracranial aneurysm is defined as a localized dilatation of the cerebral arteries, which can potentially lead to rupture and subsequent hemorrhagic stroke. The mechanisms by which aneurysms develop and grow remain unknown. The objective of this project is to utilize MRI, a routine non-invasive examination for detecting and following up aneurysms, to identify visually and quantitatively an aneurysm growth and relevant biomarkers that can predict the risk of aneurysm development.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
inclusion criteria: * Patients with one or more unruptured intracranial aneurysms followed up at the participating center. Patients may have other ruptured and/or treated aneurysms * Patient older than 18 years * Patient consenting to participate to the study * Patient enrolled in the national healthcare insurance program exclusion criteria: * Patients who have already received surgical or endovascular treatment for all their aneurysm(s), or who are due to receive such treatment in less than 2 months. * Patients with only ruptured aneurysm(s) * Patients with arteriovenous malformations (treated or untreated) * Patients with a contraindication to MRI * Patients with an allergy to one of the contrast agents (Iodixanol, Gadoteric acid) * Pregnant or breast-feeding patients * Patients protected by law.
💊

What it tests

  • Additional 4D Flow MRI or additional 4D Flow sequence
📍

Where

1 site
Damien JOLLY
Reims, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy